Royal Bank of Canada »

Aardvark Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.0k 305 13.11
2025-06-30 $0 268 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Group
Adage Capital Partners GP
Millennium Management
BlackRock
Silverarc Capital Management
Schonfeld Strategic Advisors
Geode Capital Management
Cresset Asset Management
Cantor Fitzgerald, L. P.
State Street Corporation
Two Sigma Investments
Northern Trust

View all funds holding Aardvark Therapeutics